Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2016

01.02.2016 | Research Article

Analysis of drug-related problems in three departments of a German University hospital

verfasst von: Rebekka Lenssen, Axel Heidenreich, Jörg B. Schulz, Christian Trautwein, Christina Fitzner, Ulrich Jaehde, Albrecht Eisert

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

During the last decades, pharmaceutical care services have been developed and implemented to optimize drug therapies and ensure medication safety. To investigate the need for pharmaceutical care services, drug-related problems can be measured.

Objective

Thus, the aim of this study was to analyse number, type and occurrence of drug-related problems in different clinical departments.

Setting

A pharmaceutical care service was established on general wards in Urology, Neurology and Gastroenterology at the University Hospital RWTH Aachen, Germany.

Method

For each of a total of 306 patients, a pharmacist conducted an extended medication history, performed medication reconciliation, conducted medication safety checks and if drug-related problems were discovered, gave valid recommendations to the attending healthcare team. Drug-related problems were classified using the APS-Doc system. For statistical analyses, SAS® 9.1.3, SAS Institute, Cary NC, USA was applied. The project was approved by the local ethics committee.

Main outcome measure

Type, occurrence and frequency of DRP in different medical departments.

Results

On average, 2.3 drug-related problems per patient were documented for all three departments. Drug-related problems were found in each category of the APS-Doc system. The most pronounced drug-related problems found were drug–drug interactions (34.6 %). 37 % of the identified drug-related problems occurred before hospital admission, 27 % during transitional care, and 36 % on the ward. Subgroup analysis revealed specific drug-related problem patterns for each clinical department. The number of drug-related problems was found to be associated with the number of drugs and age.

Conclusion

Drug-related problems frequently occur in all investigated clinical departments. A holistic pharmaceutical care service could be an option to address this issue. In case of limited resources, individual drug-related problem patterns can be used as a basis for a tailored pharmaceutical care service. As number of drugs and age have been shown to be significant risk factors, it is crucial that the healthcare team including the pharmacist pays special attention to elderly patients and those with polymedication.
Literatur
2.
Zurück zum Zitat Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013;144:1687–95.CrossRefPubMed Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013;144:1687–95.CrossRefPubMed
3.
Zurück zum Zitat MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–9.CrossRefPubMed MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–9.CrossRefPubMed
4.
Zurück zum Zitat Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed
5.
Zurück zum Zitat Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19:556–64.CrossRefPubMed Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19:556–64.CrossRefPubMed
6.
Zurück zum Zitat Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006;333:522.CrossRefPubMedPubMedCentral Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006;333:522.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.CrossRefPubMed Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.CrossRefPubMed
8.
Zurück zum Zitat Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67:741–52.CrossRefPubMed Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67:741–52.CrossRefPubMed
9.
Zurück zum Zitat Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.CrossRefPubMed Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.CrossRefPubMed
10.
Zurück zum Zitat Stange D, Kriston L, von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013;19:396–407.PubMed Stange D, Kriston L, von-Wolff A, Baehr M, Dartsch DC. Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence. J Manag Care Pharm. 2013;19:396–407.PubMed
11.
Zurück zum Zitat Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34:828–31.CrossRefPubMed Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34:828–31.CrossRefPubMed
12.
Zurück zum Zitat Liekweg A, Westfeld M, Braun M, Zivanovic O, Schink T, Kuhn W, et al. Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer. 2012;20:2669–77.CrossRefPubMedPubMedCentral Liekweg A, Westfeld M, Braun M, Zivanovic O, Schink T, Kuhn W, et al. Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer. 2012;20:2669–77.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kantelhardt P. Unterstützung ärztlicher Tätigkeiten-Welchen Beitrag leisten Krankenhausapotheker schon heute? Krankenhauspharmazie. 2009;30:201–5. Kantelhardt P. Unterstützung ärztlicher Tätigkeiten-Welchen Beitrag leisten Krankenhausapotheker schon heute? Krankenhauspharmazie. 2009;30:201–5.
14.
Zurück zum Zitat Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci. 2010;32:194–9.CrossRefPubMed Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci. 2010;32:194–9.CrossRefPubMed
15.
Zurück zum Zitat Hohmann C, Eickhoff C, Klotz JM, Schulz M, Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Ther. 2012;37:276–81.CrossRefPubMed Hohmann C, Eickhoff C, Klotz JM, Schulz M, Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Ther. 2012;37:276–81.CrossRefPubMed
16.
Zurück zum Zitat Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. 3rd ed. Cary: SAS institute; 2012. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. 3rd ed. Cary: SAS institute; 2012.
17.
Zurück zum Zitat Altman DG. Practical statistics for medical researchers. 1st ed. London: Chapman & Hall; 1991. Altman DG. Practical statistics for medical researchers. 1st ed. London: Chapman & Hall; 1991.
18.
Zurück zum Zitat Beckett RD, Crank CW, Wehmeyer A. Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients. J Pharm Pract. 2012;25:136–41.CrossRefPubMed Beckett RD, Crank CW, Wehmeyer A. Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients. J Pharm Pract. 2012;25:136–41.CrossRefPubMed
19.
Zurück zum Zitat Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36:430–7.CrossRefPubMedPubMedCentral Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36:430–7.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Lau HS, Florax C, Porsius AJ, De Boer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol. 2000;49:597–603.CrossRefPubMedPubMedCentral Lau HS, Florax C, Porsius AJ, De Boer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol. 2000;49:597–603.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006;15:122–6.CrossRefPubMedPubMedCentral Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006;15:122–6.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kraehenbuehl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30:777–86.CrossRef Kraehenbuehl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30:777–86.CrossRef
23.
Zurück zum Zitat Nicolas A, Eickhoff C, Griese N, Schulz M. Drug-related problems in prescribed medicines in Germany at the time of dispensing. Int J Clin Pharm. 2013;35:476–82.CrossRefPubMed Nicolas A, Eickhoff C, Griese N, Schulz M. Drug-related problems in prescribed medicines in Germany at the time of dispensing. Int J Clin Pharm. 2013;35:476–82.CrossRefPubMed
24.
Zurück zum Zitat Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28:152–8.CrossRefPubMed Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28:152–8.CrossRefPubMed
25.
Zurück zum Zitat Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30:768–76.CrossRefPubMed
26.
Zurück zum Zitat Schorr SG, Eickhoff C, Feldt S, Hohmann C, Schulz M. Exploring the potential impact of hospital ward-based pharmacy interns on drug safety. Pharmazie. 2014;69:316–20.PubMed Schorr SG, Eickhoff C, Feldt S, Hohmann C, Schulz M. Exploring the potential impact of hospital ward-based pharmacy interns on drug safety. Pharmazie. 2014;69:316–20.PubMed
27.
Zurück zum Zitat Kjeldsen LJ, Clemmensen MH, Kronborg C, Hedegaard U, Larsen LH, Yderstraede IO, et al. Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications. Int J Clin Pharm. 2014;36:368–76.CrossRefPubMed Kjeldsen LJ, Clemmensen MH, Kronborg C, Hedegaard U, Larsen LH, Yderstraede IO, et al. Evaluation of a controlled, national collaboration study on a clinical pharmacy service of screening for risk medications. Int J Clin Pharm. 2014;36:368–76.CrossRefPubMed
28.
Zurück zum Zitat Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38:942–8.CrossRefPubMed Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38:942–8.CrossRefPubMed
29.
Zurück zum Zitat Nielsen TR, Andersen SE, Rasmussen M, Honore PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35:1137–51.CrossRefPubMed Nielsen TR, Andersen SE, Rasmussen M, Honore PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35:1137–51.CrossRefPubMed
30.
Zurück zum Zitat Hassan Y, Kassab Y. Abd Aziz N, Akram H, Ismail O. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge. J Clin Pharm Ther. 2013;38:97–100.CrossRefPubMed Hassan Y, Kassab Y. Abd Aziz N, Akram H, Ismail O. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge. J Clin Pharm Ther. 2013;38:97–100.CrossRefPubMed
31.
Zurück zum Zitat Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–2, 834–6. Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25:830–2, 834–6.
32.
Zurück zum Zitat Kjeldsen LJ, Birkholm T, Fischer H, Graabaek T, Kibsdal KP, Ravn-Nielsen LV, et al. Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals. Int J Clin Pharm. 2014;36:734–41.CrossRefPubMed Kjeldsen LJ, Birkholm T, Fischer H, Graabaek T, Kibsdal KP, Ravn-Nielsen LV, et al. Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals. Int J Clin Pharm. 2014;36:734–41.CrossRefPubMed
33.
Zurück zum Zitat Stemer G, Lemmens-Gruber R. The clinical pharmacist’s contributions within the multidisciplinary patient care team of an intern nephrology ward. Int J Clin Pharm. 2011;33:759–62.CrossRefPubMed Stemer G, Lemmens-Gruber R. The clinical pharmacist’s contributions within the multidisciplinary patient care team of an intern nephrology ward. Int J Clin Pharm. 2011;33:759–62.CrossRefPubMed
34.
Zurück zum Zitat Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14:447–50.CrossRefPubMed Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14:447–50.CrossRefPubMed
35.
Zurück zum Zitat Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed
36.
Zurück zum Zitat Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29–34.CrossRefPubMed Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29–34.CrossRefPubMed
38.
Zurück zum Zitat Kaboli P. Realizing the pharmacoeconomic benefit of clinical pharmacy. Am J Health Syst Pharm. 2008;65:1123.CrossRefPubMed Kaboli P. Realizing the pharmacoeconomic benefit of clinical pharmacy. Am J Health Syst Pharm. 2008;65:1123.CrossRefPubMed
39.
Zurück zum Zitat De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65:1161–72.CrossRefPubMed De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65:1161–72.CrossRefPubMed
Metadaten
Titel
Analysis of drug-related problems in three departments of a German University hospital
verfasst von
Rebekka Lenssen
Axel Heidenreich
Jörg B. Schulz
Christian Trautwein
Christina Fitzner
Ulrich Jaehde
Albrecht Eisert
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0213-1

Weitere Artikel der Ausgabe 1/2016

International Journal of Clinical Pharmacy 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.